Skip to main content
. 2013 Sep 24;305(10):E1292–E1298. doi: 10.1152/ajpendo.00441.2013

Table 2.

Cardiometabolic risk factors

IFG IGT IFG + IGT
SBP, mmHg
    Pre 130.6 ± 3.1 138.7 ± 6.7 135.0 ± 6.2
    Δ −7.7 ± 5.9 −17.8 ± 2.9* −11.0 ± 4.1*
DBP, mmHg
    Pre 78.0 ± 3.8 83.3 ± 2.7 84.8 ± 4.2
    Δ −5.7 ± 4.9 −9.7 ± 2.2* −9.8 ± 4.2*
FFA, mEq/l
    Pre 0.52 ± 0.03 0.57 ± 0.04 0.58 ± 0.5
    Δ 0.03 ± 0.05 −0.01 ± 0.04 0.01 ± 0.05
TG, mg/dl#
    Pre 144.1 ± 23.5 136.9 ± 19.9 127.5 ± 19.6
    Δ −52.8 ± 15.9* −18.9 ± 18.4 −25.3 ± 7.2*
TC, mg/dl
    Pre 209.5 ± 12.3 197.7 ± 7.5 198.8 ± 12.6
    Δ −37.8 ± 9.7* −15.4 ± 6.5* −23.9 ± 5.3*
HDL, mg/dl
    Pre 42.8 ± 3.7 50.0 ± 5.9 42.4 ± 4.7
    Δ −0.5 ± 2.1 −5.7 ± 2.6 −3.2 ± 2.4
LDL, mg/dl
    Pre 130.1 ± 9.1 125.7 ± 8.5 136.1 ± 8.0
    Δ −22 ± 9.3* −6.1 ± 7.4 −17.0 ± 4.0*

Data are means ± SE. SBP, systolic blood pressure; DBP, diastolic blood pressure; FFA, free fatty acid; TG, triglyceride; TC, total cholesterol.

#

Data were log transformed for statistical analysis but are presented herein as raw values. ANOVA was performed to detect between-group differences. Within effect (paired t-test;

*

P < 0.05).